Tyler Stone Wealth Management Increases Stake in Nutrien Ltd.

Tyler Stone Wealth Management has increased its investment in Nutrien Ltd. (NYSE:NTR - Free Report) by 24.7% during the fourth quarter, as revealed in its latest disclosure to the Securities and Exchange Commission (SEC). Following an acquisition of an additional 5,470 shares, the institutional investor now holds a total of 27,640 shares of Nutrien's stock, which is valued at approximately $1,237,000 based on the most recent SEC filing.

Other Institutional Changes

In addition to Tyler Stone Wealth Management, several other hedge funds have adjusted their holdings in Nutrien during the same timeframe. For instance, Uncommon Cents Investing LLC increased its stake by 2.1%, bringing its total to 11,550 shares, valued at around $517,000 after acquiring an additional 235 shares. Rhumbline Advisers also raised its position by 3.5%, now owning 7,398 shares valued at $331,000 after purchasing 247 shares. Furthermore, FFT Wealth Management LLC boosted its investment by 0.9%, holding 29,732 shares worth $1,330,000 following an acquisition of 277 shares in the quarter.

EverSource Wealth Advisors LLC also expanded its position in Nutrien by 23.9%, acquiring an additional 348 shares to reach 1,804 shares valued at $81,000. Lastly, Kingsview Wealth Management LLC grew its holdings by 3.3%, owning 11,317 shares worth $544,000 after a purchase of 365 shares earlier. Overall, institutional investors and hedge funds collectively own 63.10% of Nutrien's stock.

Analysts' Ratings and Forecast

Many Wall Street analysts have provided their insights on Nutrien's stock recently. The Royal Bank of Canada reiterated an "outperform" rating, setting a target price of $60.00. Raymond James upgraded Nutrien's position from "market perform" to "outperform," increasing its price target from $58.00 to $60.00. Mizuho raised their price target from $52.00 to $55.00 while maintaining a "neutral" rating. Oppenheimer also initiated coverage on Nutrien with an "outperform" rating and a $60.00 target price.

In comparison, The Goldman Sachs Group has initiated coverage with a "sell" rating and offered a target price of $53.00. Currently, the consensus among analysts includes two sell ratings, five hold ratings, and nine buy ratings, with overall forecasts suggesting a "Hold" rating and an average target price of $60.13.

Nutrien's Stock Performance

Nutrien's shares opened at $50.19 on Wednesday, with a 52-week range between $43.70 and $60.87. The company reports a quick ratio of 0.82, a current ratio of 1.27, and a debt-to-equity ratio of 0.38. Nutrien’s market cap stands at $24.56 billion, with a price-to-earnings ratio of 36.64 and a PEG ratio of 1.19. The firm’s 50-day moving average is $51.67, while its 200-day moving average is $48.91.

Recent Financial Results

In its latest quarterly earnings report released on February 19th, Nutrien reported earnings per share (EPS) of $0.28, which was below analysts' expectations of $0.37, missing by $0.09. The company's revenue for the quarter stood at $5.08 billion, closely following the $5.09 billion analyst consensus. Nutrien's net margin was recorded at 2.62%, alongside a return on equity of 6.81%. Moving forward, analysts predict that Nutrien Ltd. will post an EPS of 3.72 for the current fiscal year.

Dividend Information

Nutrien recently announced a quarterly dividend, scheduled for payment on April 10th. Shareholders who are on record as of March 31st will receive a dividend of $0.545 per share, which translates to an annualized dividend of $2.18, yielding 4.34%. The ex-dividend date is set for March 31st, and the current dividend payout ratio (DPR) is 159.12%.

Company Overview

Nutrien Ltd. specializes in providing crop inputs and services. It operates through four main segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment supplies crop nutrients, crop protection products, seeds, and related merchandise, while the Potash segment offers both granular and standard potash products.

Tyler, Nutrien, Investment